📰 Alkermes News
Page 47 - Alkermes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.
December 9, 2022
Addiction Treatment Market Size Projected to Reach ~US$ 12 Bn by 2030
December 9, 2022
Addiction Treatment Market Size Projected to Reach ~US$ 12 Bn by 2030
December 9, 2022
Addiction Treatment Market Size Projected to Reach ~US$ 12 Bn by 2030
December 8, 2022
NORTHAMPTON, MA / ACCESSWIRE / December 8, 2022 / Alkermes:For some people living with alcohol dependence, families play a support role. In fact, 47% of adults who sought treatment did so because a family
December 6, 2022
– Dr. Craig Hopkinson, currently EVP of Research & Development and Chief Medical Officer at Alkermes, brings strong global orphan drug development expertise – Dr. Paul Streck, former... | December 6, 2022
December 6, 2022
NORTHAMPTON, MA / ACCESSWIRE / December 6, 2022 / AlkermesOriginally published in Alkermes 2021 Corporate ResponsibilityWe have developed and now manufacture and commercialize proprietary medicines for
December 1, 2022
NORTHAMPTON, MA / ACCESSWIRE / December 1, 2022 / This Giving Tuesday, we are thankful for the employees who take time to support people in our communities who are in need. 10+ years ago, we launched Alkermes
November 30, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat as part of the BofA Securities 2022 Biotech...
November 30, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat as part of the BofA Securities 2022 Biotech...
November 30, 2022
DUBLIN, Nov. 30, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat as part of the BofA Securities 2022 Biotech SMID Cap Conference